Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Håkan Olsson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Geographic Areas

Sweden

Genes & Molecular Sequences

BRCA1 Genes

Concepts & Ideas

Physiology

Chemicals & Drugs

Procedures

Case-Control Studies

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
64
Borg, Ake
26
Ingvar, Christian
23
Johannsson, Oskar
23
Fernö, Mårten
19
Kristoffersson, Ulf
18
Jernström, Helena
16
Westerdahl, Johan
15
Loman, Niklas
14
Ranstam, Jonas
13
Baldetorp, Bo
12
Killander, Dick
12
Måsbäck, Anna
11
Jonsson, Nils
11
Bladström, Anna
9
Sandberg, Therese

Sign-in to see all Coauthors

Publications

TOP 3
Rennstam Karin; Ringberg Anita; Cunliffe Heather E; Olsson Håkan; Landberg Göran; Hedenfalk Ingrid
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
Ericson Ulrika C; Ivarsson Malin I L; Sonestedt Emily; Gullberg Bo; Carlson Joyce; Olsson Håkan; Wirfält Elisabet
Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele.
Sjövall Katarina; Attner Bo; Lithman Thor; Noreen Dennis; Gunnars Barbro; Thomé Bibbi; Olsson Håkan
Influence on the health of the partner affected by tumor disease in the wife or husband based on a population-based register study of cancer in Sweden.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Håkan Olsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Rennstam Karin; Ringberg Anita; Cunliffe Heather E; Olsson Håkan; Landberg Göran; Hedenfalk Ingrid
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
Genes, chromosomes & cancer 2010;49(1):78-90.
2009: Ericson Ulrika C; Ivarsson Malin I L; Sonestedt Emily; Gullberg Bo; Carlson Joyce; Olsson Håkan; Wirfält Elisabet
Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele.
The American journal of clinical nutrition 2009;90(5):1380-9.
2009: Sjövall Katarina; Attner Bo; Lithman Thor; Noreen Dennis; Gunnars Barbro; Thomé Bibbi; Olsson Håkan
Influence on the health of the partner affected by tumor disease in the wife or husband based on a population-based register study of cancer in Sweden.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4781-6.
2009: Epstein E; Lindqvist P G; Geppert B; Olsson H
A population-based cohort study on sun habits and endometrial cancer.
British journal of cancer 2009;101(3):537-40.
2009: Wallström P; Bjartell A; Gullberg B; Olsson H; Wirfält E
A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk.
British journal of cancer 2009;100(11):1799-805.
2009: Sonestedt Emily; Ivarsson Malin I L; Harlid Sophia; Ericson Ulrika; Gullberg Bo; Carlson Joyce; Olsson Håkan; Adlercreutz Herman; Wirfält Elisabet
The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes.
The Journal of nutrition 2009;139(5):993-1001.
2009: Ericson Ulrika; Sonestedt Emily; Ivarsson Malin I L; Gullberg Bo; Carlson Joyce; Olsson Håkan; Wirfält Elisabet
Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(4):1101-10.
2009: Lindqvist P G; Epstein E; Olsson H
Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis.
Journal of thrombosis and haemostasis : JTH 2009;7(4):605-10.
2009: Lindqvist Pelle G; Epstein Elisabeth; Olsson Håkan
The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study.
British journal of haematology 2009;144(2):234-40.
2009: Broberg Karin; Huynh Elizabeth; Schläwicke Engström Karin; Björk Jonas; Albin Maria; Ingvar Christian; Olsson Håkan; Höglund Mattias
Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.
BMC cancer 2009;9():140.
2008: Sonestedt Emily; Borgquist Signe; Ericson Ulrika; Gullberg Bo; Olsson Håkan; Adlercreutz Herman; Landberg Göran; Wirfält Elisabet
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(11):3241-51.
2008: Jernström H; Henningson M; Johansson U; Olsson H
Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer.
British journal of cancer 2008;99(9):1534-8.
2008: Sonestedt Emily; Borgquist Signe; Ericson Ulrika; Gullberg Bo; Landberg Göran; Olsson Håkan; Wirfält Elisabet
Plant foods and oestrogen receptor alpha- and beta-defined breast cancer: observations from the Malmo Diet and Cancer cohort.
Carcinogenesis 2008;29(11):2203-9.
2008: Sonestedt Emily; Ericson Ulrika; Gullberg Bo; Skog Kerstin; Olsson Håkan; Wirfält Elisabet
Do both heterocyclic amines and omega-6 polyunsaturated fatty acids contribute to the incidence of breast cancer in postmenopausal women of the Malmö diet and cancer cohort?
International journal of cancer. Journal international du cancer 2008;123(7):1637-43.
2008: Olsson H; Magnusson S; Bladström A
Lower breast cancer survival in mothers of children with a malignancy: a national study.
British journal of cancer 2008;98(11):1876-8.
2008: Carlsson Anders; Wingren Christer; Ingvarsson Johan; Ellmark Peter; Baldertorp Bo; Fernö Mårten; Olsson Håkan; Borrebaeck Carl A K
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
European journal of cancer (Oxford, England : 1990) 2008;44(3):472-80.
2008: Nielsen K; Masback A; Bladstrom A; Lundgren L; Jonsson N; Borg A; Ingvar C; Olsson H
Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
The British journal of dermatology 2008;158(2):429-31.
2008: Saal Lao H; Gruvberger-Saal Sofia K; Persson Camilla; Lövgren Kristina; Jumppanen Mervi; Staaf Johan; Jönsson Göran; Pires Maira M; Maurer Matthew; Holm Karolina; Koujak Susan; Subramaniyam Shivakumar; Vallon-Christersson Johan; Olsson Håkan; Su Tao; Memeo Lorenzo; Ludwig Thomas; Ethier Stephen P; Krogh Morten; Szabolcs Matthias; Murty Vundavalli V V S; Isola Jorma; Hibshoosh Hanina; Parsons Ramon; Borg Ake
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
Nature genetics 2008;40(1):102-7.
2008: Magnusson Susanne; Borg Ake; Kristoffersson Ulf; Nilbert Mef; Wiebe Thomas; Olsson Håkan
Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes.
Familial cancer 2008;7(4):331-7.
2008: Hietala Maria; Olsson Håkan; Jernström Helena
Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk.
Familial cancer 2008;7(3):221-8.
2007: Broberg Karin; Höglund Mattias; Gustafsson Cecilia; Björk Jonas; Ingvar Christian; Albin Maria; Olsson Håkan
Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma.
Cancer letters 2007;258(1):38-44.
2007: Henningson M; Johansson U; Borg A; Olsson H; Jernström Helena
CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
Molecular human reproduction 2007;13(4):231-6.
2007: Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Human reproduction (Oxford, England) 2007;22(1):83-91.
2007: Henningson Maria; Bågeman Erika; Sandberg Therese; Borg Ake; Olsson Håkan; Jernström Helena
Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
Familial cancer 2007;6(4):445-52.
2006: Fernebro J; Bladström A; Rydholm A; Gustafson P; Olsson H; Engellau J; Nilbert M
Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients.
British journal of cancer 2006;95(8):986-90.
2006: Jernström Helena; Sellberg Gunilla; Borg Ake; Olsson Hakan
Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2006;15(3):233-41.
2006: Gronwald Jacek; Tung Nadine; Foulkes William D; Offit Kenneth; Gershoni Ruth; Daly Mary; Kim-Sing Charmaine; Olsson Hakan; Ainsworth Peter; Eisen Andrea; Saal Howard; Friedman Eitan; Olopade Olufunmilayo; Osborne Michael; Weitzel Jeffrey; Lynch Henry; Ghadirian Parviz; Lubinski Jan; Sun Ping; Narod Steven A;
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
International journal of cancer. Journal international du cancer 2006;118(9):2281-4.
2006: Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():497.
2005: Cullinane Carey A; Lubinski Jan; Neuhausen Susan L; Ghadirian Parviz; Lynch Henry T; Isaacs Claudine; Weber Barbara; Moller Pal; Offit Kenneth; Kim-Sing Charmaine; Friedman Eitan; Randall Susan; Pasini Barbara; Ainsworth Peter; Gershoni-Baruch Ruth; Foulkes William D; Klijn Jan; Tung Nadine; Rennert Gad; Olopade Olufunmilayo; Couch Fergus; Wagner Teresa; Olsson Hakan; Sun Ping; Weitzel Jeffrey N; Narod Steven A
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
International journal of cancer. Journal international du cancer 2005;117(6):988-91.
2005: Jernström Helena; Loman Niklas; Johannsson Oskar T; Borg Ake; Olsson Håkan
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
European journal of cancer (Oxford, England : 1990) 2005;41(15):2312-20.
2005: Jönsson Göran; Bendahl Pär-Ola; Sandberg Therese; Kurbasic Azra; Staaf Johan; Sunde Lone; Crüger Dorthe G; Ingvar Christian; Olsson Håkan; Borg Ake
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
Journal of the National Cancer Institute 2005;97(18):1377-82.
2005: Jönsson Göran; Naylor Tara L; Vallon-Christersson Johan; Staaf Johan; Huang Jia; Ward M Renee; Greshock Joel D; Luts Lena; Olsson Håkan; Rahman Nazneen; Stratton Michael; Ringnér Markus; Borg Ake; Weber Barbara L
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Cancer research 2005;65(17):7612-21.
2005: Kotsopoulos Joanne; Lubinski Jan; Lynch Henry T; Neuhausen Susan L; Ghadirian Parviz; Isaacs Claudine; Weber Barbara; Kim-Sing Charmaine; Foulkes William D; Gershoni-Baruch Ruth; Ainsworth Peter; Friedman Eitan; Daly Mary; Garber Judy E; Karlan Beth; Olopade Olufunmilayo I; Tung Nadine; Saal Howard M; Eisen Andrea; Osborne Michael; Olsson Hakan; Gilchrist Dawna; Sun Ping; Narod Steven A
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Cancer causes & control : CCC 2005;16(6):667-74.
2005: Geborek P; Bladström A; Turesson C; Gulfe A; Petersson I F; Saxne T; Olsson H; Jacobsson L T H
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.
Annals of the rheumatic diseases 2005;64(5):699-703.
2005: Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
British journal of cancer 2005;92(5):857-66.
2004: Ericson K; Nilbert M; Bladström A; Anderson H; Olsson H; Planck M
Familial risk of tumors associated with hereditary non-polyposis colorectal cancer: a Swedish population-based study.
Scandinavian journal of gastroenterology 2004;39(12):1259-65.
2004: Jernström H; Lubinski J; Lynch H T; Ghadirian P; Neuhausen S; Isaacs C; Weber B L; Horsman D; Rosen B; Foulkes W D; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod S A
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2004;96(14):1094-8.
2004: Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
The British journal of dermatology 2004;150(3):531-6.
2004: Malander S; Ridderheim M; Måsbäck A; Loman N; Kristoffersson U; Olsson H; Nilbert M; Borg A
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.
European journal of cancer (Oxford, England : 1990) 2004;40(3):422-8.
2004: Dryver Eric; Brandt Lars; Kauppinen Timo; Olsson Håkan
Occupational exposures and non-Hodgkin's lymphoma in Southern Sweden.
International journal of occupational and environmental health 2004;10(1):13-21.
2004: Henriksson Karin; Olsson Håkan; Kristoffersson Ulf
The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
Acta oncologica (Stockholm, Sweden) 2004;43(7):637-49.
2003: Adeyinka Adewale; Baldetorp Bo; Mertens Fredrik; Olsson Håkan; Johannsson Oskar; Heim Sverre; Pandis Nikos
Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas.
Cancer genetics and cytogenetics 2003;147(1):62-7.
2003: Westman Kerstin W A; Selga Daina; Isberg Per-Erik; Bladström Anna; Olsson Håkan
High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement.
Journal of the American Society of Nephrology : JASN 2003;14(11):2926-33.
2003: Bladström Anna; Anderson Harald; Olsson Håkan
Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study.
Clinical breast cancer 2003;4(4):280-5.
2003: Olsson H; Bladström A; Ingvar C
Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?
Obstetrics and gynecology 2003;102(3):565-70.
2003: Johannsson Oskar T; Staff Synnöve; Vallon-Christersson Johan; Kytöla Soili; Gudjonsson Thorarinn; Rennstam Karin; Hedenfalk Ingrid A; Adeyinka Adewale; Kjellén Elisabeth; Wennerberg Johan; Baldetorp Bo; Petersen Ole W; Olsson Håkan; Oredsson Stina; Isola Jorma; Borg Ake
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier.
Laboratory investigation; a journal of technical methods and pathology 2003;83(3):387-96.
2003: Hedenfalk Ingrid; Ringner Markus; Ben-Dor Amir; Yakhini Zohar; Chen Yidong; Chebil Gunilla; Ach Robert; Loman Niklas; Olsson Håkan; Meltzer Paul; Borg Ake; Trent Jeffrey
Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2532-7.
2003: Ericson K; Halvarsson B; Nagel J; Rambech E; Planck M; Piotrowska Z; Olsson H; Nilbert M
Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(2):240-8.
2003: Loman Niklas; Bladström Anna; Johannsson Oskar; Borg Ake; Olsson Håkan
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.
Breast cancer research : BCR 2003;5(6):R175-86.
2002: Olsson H; Bladström A
A cohort study of reproductive factors and family history of breast cancer in southern Sweden.
Breast cancer research and treatment 2002;76(3):203-9.
2002: Måsbäck A; Olsson H; Westerdahl J; Sandberg T; Borg A; Jonsson N; Ingvar C
Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation families.
Melanoma research 2002;12(6):549-57.
2002: Planck Maria; Rambech Eva; Möslein Gabriela; Müller Wolfram; Olsson Håkan; Nilbert Mef
High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum.
Cancer 2002;94(9):2502-10.
2001: Olsson H
A hypothesis about tumour development and the clinical features of hereditary breast cancers.
European journal of cancer (Oxford, England : 1990) 2001;37(16):2023-9.
2001: Måsbäck A; Olsson H; Westerdahl J; Ingvar C; Jonsson N
Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review.
Melanoma research 2001;11(5):435-45.
2001: Olsson H; Bladström A; Ingvar C; Möller T R
A population-based cohort study of HRT use and breast cancer in southern Sweden.
British journal of cancer 2001;85(5):674-7.
2001: Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Journal of the National Cancer Institute 2001;93(16):1215-23.
2001: Hashemi J; Bendahl P O; Sandberg T; Platz A; Linder S; Stierner U; Olsson H; Ingvar C; Hansson J; Borg A
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families.
Genes, chromosomes & cancer 2001;31(2):107-16.
2001: Hedenfalk I; Duggan D; Chen Y; Radmacher M; Bittner M; Simon R; Meltzer P; Gusterson B; Esteller M; Kallioniemi O P; Wilfond B; Borg A; Trent J; Raffeld M; Yakhini Z; Ben-Dor A; Dougherty E; Kononen J; Bubendorf L; Fehrle W; Pittaluga S; Gruvberger S; Loman N; Johannsson O; Olsson H; Sauter G
Gene-expression profiles in hereditary breast cancer.
The New England journal of medicine 2001;344(8):539-48.
2001: Vallon-Christersson J; Cayanan C; Haraldsson K; Loman N; Bergthorsson J T; Brøndum-Nielsen K; Gerdes A M; Møller P; Kristoffersson U; Olsson H; Borg A; Monteiro A N
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
Human molecular genetics 2001;10(4):353-60.
2001: Brandt L; Brandt J; Olsson H; Anderson H; Möller T
Gender and time differences in initial location and histological grade of non-Hodgkin's lymphomas in Southern Sweden.
Acta oncologica (Stockholm, Sweden) 2001;40(4):479-84.
2000: Anderson H; Bladström A; Olsson H; Möller T R
Familial breast and ovarian cancer: a Swedish population-based register study.
American journal of epidemiology 2000;152(12):1154-63.
2000: Olsson H
Tumour biology of a breast cancer at least partly reflects the biology of the tissue/epithelial cell of origin at the time of initiation - a hypothesis.
The Journal of steroid biochemistry and molecular biology 2000;74(5):345-50.
2000: Kauraniemi P; Hedenfalk I; Persson K; Duggan D J; Tanner M; Johannsson O; Olsson H; Trent J M; Isola J; Borg A
MYB oncogene amplification in hereditary BRCA1 breast cancer.
Cancer research 2000;60(19):5323-8.
2000: Planck M; Wenngren E; Borg A; Olsson H; Nilbert M
Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation.
Genes, chromosomes & cancer 2000;29(1):33-9.
2000: Planck M; Anderson H; Bladström A; Möller T; Wenngren E; Olsson H
Increased cancer risk in offspring of women with colorectal carcinoma: a Swedish register-based cohort study.
Cancer 2000;89(4):741-9.
2000: Borg A; Sandberg T; Nilsson K; Johannsson O; Klinker M; Måsbäck A; Westerdahl J; Olsson H; Ingvar C
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
Journal of the National Cancer Institute 2000;92(15):1260-6.
2000: Olsson H
Estrogen receptor content in malignant breast tumors in men--a review.
Journal of mammary gland biology and neoplasia 2000;5(3):283-7.
2000: Loman N; Johannsson O; Bendahl P; Dahl N; Einbeigi Z; Gerdes A; Borg A; Olsson H
Prognosis and clinical presentation of BRCA2-associated breast cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(11):1365-73.
2000: Westerdahl J; Ingvar C; Mâsbäck A; Olsson H
Sunscreen use and malignant melanoma.
International journal of cancer. Journal international du cancer 2000;87(1):145-50.
2000: Westerdahl J; Ingvar C; Måsbäck A; Jonsson N; Olsson H
Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity.
British journal of cancer 2000;82(9):1593-9.
2000: Bratt O; Damber J E; Emanuelsson M; Kristoffersson U; Lundgren R; Olsson H; Grönberg H
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(2):235-41.
1999: Jernström H C; Johannsson O T; Loman N; Borg A; Olsson H
Reproductive factors in hereditary breast cancer.
Breast cancer research and treatment 1999;58(3):295-301.
1999: Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang Q X; Olsson H
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
British journal of cancer 1999;81(4):672-6.
1999: Planck M; Koul A; Fernebro E; Borg A; Kristoffersson U; Olsson H; Wenngren E; Mangell P; Nilbert M
hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden.
International journal of cancer. Journal international du cancer 1999;83(2):197-202.
1999: Johannsson O; Loman N; Möller T; Kristoffersson U; Borg A; Olsson H
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.
European journal of cancer (Oxford, England : 1990) 1999;35(8):1248-57.
1999: Jernström H; Frenander J; Fernö M; Olsson H
Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.
British journal of cancer 1999;80(9):1453-8.
1999: Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma: a population-based study.
Melanoma research 1999;9(2):189-97.
1999: Bratt O; Kristoffersson U; Lundgren R; Olsson H
Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study.
European journal of cancer (Oxford, England : 1990) 1999;35(2):272-7.
1999: Tirkkonen M; Kainu T; Loman N; Jóhannsson O T; Olsson H; Barkardóttir R B; Kallioniemi O P; Borg A
Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer.
Genes, chromosomes & cancer 1999;24(1):56-61.
1998: Johannsson O; Loman N; Borg A; Olsson H
Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers.
Lancet 1998;352(9137):1359-60.
1998: Narod S A; Risch H; Moslehi R; Dørum A; Neuhausen S; Olsson H; Provencher D; Radice P; Evans G; Bishop S; Brunet J S; Ponder B A
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
The New England journal of medicine 1998;339(7):424-8.
1998: Loman N; Johannsson O; Bendahl P O; Borg A; Fernö M; Olsson H
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
Cancer 1998;83(2):310-9.
1998: Westman K W; Bygren P G; Olsson H; Ranstam J; Wieslander J
Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.
Journal of the American Society of Nephrology : JASN 1998;9(5):842-52.
1998: Bratt O; Abrahamsson P A; Lundgren R; Olsson H; Kristoffersson U
[Research progress on hereditary prostatic cancer. Families at risk should be surveyed and screening should be offered]
Läkartidningen 1998;95(14):1494-6.
1998: Haraldsson K; Loman N; Zhang Q X; Johannsson O; Olsson H; Borg A
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
Cancer research 1998;58(7):1367-71.
1998: Jernström H; Johannsson O; Borg A; Ivarsson H; Olsson H
BRCA1-positive patients are small for gestational age compared with their unaffected relatives.
European journal of cancer (Oxford, England : 1990) 1998;34(3):368-71.
1998: Jóhannsson O T; Ranstam J; Borg A; Olsson H
Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):397-404.
1998: Bratt O; Kristoffersson U; Olsson H; Lundgren R
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor.
European urology 1998;34(1):19-24.
1997: Bratt O; Kristoffersson U; Lundgren R; Olsson H
The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study.
European journal of cancer (Oxford, England : 1990) 1997;33(13):2237-40.
1997: Elfving P; Mandahl N; Lundgren R; Limon J; Bak-Jensen E; Fernö M; Olsson H; Mitelman F
Prognostic implications of cytogenetic findings in kidney cancer.
British journal of urology 1997;80(5):698-706.
1997: Bratt O; Kristoffersson U; Lundgren R; Olsson H
Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing.
Urology 1997;50(3):360-5.
1997: Jernström H C; Olsson H; Borg A
Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1997;6(4):330-40.
1997: Håkansson S; Johannsson O; Johansson U; Sellberg G; Loman N; Gerdes A M; Holmberg E; Dahl N; Pandis N; Kristoffersson U; Olsson H; Borg A
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
American journal of human genetics 1997;60(5):1068-78.
1997: Johannsson O; Ranstam J; Borg A; Olsson H
BRCA1 mutations and survival in women with ovarian cancer.
The New England journal of medicine 1997;336(17):1255-6; author reply 1256-7.
1997: Tirkkonen M; Johannsson O; Agnarsson B A; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir R B; Borg A; Kallioniemi O P
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Cancer research 1997;57(7):1222-7.
1997: Jernström H; Olsson H
Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years.
American journal of epidemiology 1997;145(7):571-80.
1997: Jóhannsson O T; Idvall I; Anderson C; Borg A; Barkardóttir R B; Egilsson V; Olsson H
Tumour biological features of BRCA1-induced breast and ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(3):362-71.
1997: Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Cancer 1997;79(2):275-83.
1996: van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
British journal of cancer 1996;74(10):1615-9.
1996: Lewold S; Olsson H; Gustafson P; Rydholm A; Lidgren L
Overall cancer incidence not increased after prosthetic knee replacement: 14,551 patients followed for 66,622 person-years.
International journal of cancer. Journal international du cancer 1996;68(1):30-3.
1996: Petersson C; Pandis N; Mertens F; Adeyinka A; Ingvar C; Ringberg A; Idvall I; Bondeson L; Borg A; Olsson H; Kristoffersson U; Mitelman F
Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families.
Genes, chromosomes & cancer 1996;16(3):185-8.
1996: Sun X F; Johannsson O; Håkansson S; Sellberg G; Nordenskjöld B; Olsson H; Borg A
A novel p53 germline alteration identified in a late onset breast cancer kindred.
Oncogene 1996;13(2):407-11.
1996: Borg A; Johannsson U; Johannsson O; Häkansson S; Westerdahl J; Mäsbäck A; Olsson H; Ingvar C
Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
Cancer research 1996;56(11):2497-500.
1996: Fernö M; Bendahl P O; Borg A; Brundell J; Hirschberg L; Olsson H; Killander D
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):793-801.
1996: Brandt L; Brandt J; Olsson H; Anderson H; Möller T
Blood transfusion as a risk factor for non-Hodgkin lymphoma.
British journal of cancer 1996;73(9):1148-51.
1996: Westerdahl J; Olsson H; Måsbäck A; Ingvar C; Jonsson N
Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors.
British journal of cancer 1996;73(9):1126-31.
1996: Westerdahl J; Anderson H; Olsson H; Ingvar C
Reproducibility of a self-administered questionnaire for assessment of melanoma risk.
International journal of epidemiology 1996;25(2):245-51.
1996: Pandis N; Idvall I; Bardi G; Jin Y; Gorunova L; Mertens F; Olsson H; Ingvar C; Beroukas K; Mitelman F; Heim S
Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases.
International journal of cancer. Journal international du cancer 1996;66(2):191-6.
1996: Johannsson O; Ostermeyer E A; Håkansson S; Friedman L S; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King M C; Borg A
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
American journal of human genetics 1996;58(3):441-50.
1996: Olsson H; Jernström H; Alm P; Kreipe H; Ingvar C; Jönsson P E; Rydén S
Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors.
Breast cancer research and treatment 1996;40(2):187-96.
1996: Olsson H; Borg A
Genetic predisposition to breast cancer.
Acta oncologica (Stockholm, Sweden) 1996;35(1):1-8.
1995: Jernstrom H; Knutsson M; Olsson H
Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.
Contraception 1995;52(1):51-6.
1995: Westerdahl J; Olsson H; Måsbäck A; Ingvar C; Jonsson N
Is the use of sunscreens a risk factor for malignant melanoma?
Melanoma research 1995;5(1):59-65.
1995: Fernö M; Baldetorp B; Bendahl P O; Borg A; Ewers S B; Olsson H; Rydén S; Sigurdsson H; Killander D
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.
Breast cancer research and treatment 1995;36(1):23-34.
1994: Westerdahl J; Olsson H; Måsbäck A; Ingvar C; Jonsson N; Brandt L; Jönsson P E; Möller T
Use of sunbeds or sunlamps and malignant melanoma in southern Sweden.
American journal of epidemiology 1994;140(8):691-9.
1994: Borg A; Baldetorp B; Fernö M; Killander D; Olsson H; Rydén S; Sigurdsson H
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.
Cancer letters 1994;81(2):137-44.
1994: Borg A; Zhang Q X; Johannsson O; Olsson H
High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas.
Journal of the National Cancer Institute 1994;86(10):792-4.
1994: Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Cancer 1994;73(6):1625-30.
1994: Fernö M; Baldetorp B; Borg A; Brouillet J P; Olsson H; Rochefort H; Sellberg G; Sigurdsson H; Killander D
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2042-8.
1994: Jernström H; Olsson H
Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives.
Gynecologic and obstetric investigation 1994;38(4):261-5.
1994: Westerdahl J; Olsson H; Ingvar C
At what age do sunburn episodes play a crucial role for the development of malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1994;30A(11):1647-54.
1993: Olsson H; Andersson H; Johansson O; Möller T R; Kristoffersson U; Wenngren E
Population-based cohort investigations of the risk for malignant tumors in first-degree relatives and wives of men with breast cancer.
Cancer 1993;71(4):1273-8.
1993: Blomberg J; Möller T; Olsson H; Anderson H; Jonsson M
Cancer morbidity in blood recipients--results of a cohort study.
European journal of cancer (Oxford, England : 1990) 1993;29A(15):2101-5.
1992: Jernström H; Knutsson M; Taskila P; Olsson H
Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits.
Contraception 1992;46(6):543-8.
1992: Borg A; Zhang Q X; Olsson H; Wenngren E
Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.
Genes, chromosomes & cancer 1992;5(4):311-20.
1992: Westerdahl J; Olsson H; Ingvar C; Brandt L; Jönsson P E; Möller T
Southern travelling habits with special reference to tumour site in Swedish melanoma patients.
Anticancer research 1992;12(5):1539-42.
1992: Olsson H; Hägglund G
Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures.
American journal of epidemiology 1992;136(4):422-7.
1992: Borg A; Baldetorp B; Fernö M; Olsson H; Sigurdsson H
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.
International journal of cancer. Journal international du cancer 1992;51(5):687-91.
1992: Borg A; Zhang Q X; Alm P; Olsson H; Sellberg G
The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
Cancer research 1992;52(10):2991-4.
1992: Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Acta oncologica (Stockholm, Sweden) 1992;31(2):157-65.
1992: Fernö M; Baldetorp B; Ewers S B; Idvall I; Olsson H; Sigurdsson H; Killander D
One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?
Cytometry 1992;13(3):241-9.
1992: Maraste R; Brandt L; Olsson H; Ryde-Brandt B
Anxiety and depression in breast cancer patients at start of adjuvant radiotherapy. Relations to age and type of surgery.
Acta oncologica (Stockholm, Sweden) 1992;31(6):641-3.
1992: Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
Cytometry 1992;13(6):577-85.
1991: Olsson H; Borg A; Fernö M; Ranstam J; Sigurdsson H
Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.
Journal of the National Cancer Institute 1991;83(20):1483-7.
1991: Olsson H; Ranstam J; Baldetorp B; Ewers S B; Fernö M; Killander D; Sigurdsson H
Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.
Cancer 1991;67(5):1285-90.
1991: Borg A; Sigurdsson H; Clark G M; Fernö M; Fuqua S A; Olsson H; Killander D; McGurie W L
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.
British journal of cancer 1991;63(1):136-42.
1991: Borg A; Baldetorp B; Fernö M; Killander D; Olsson H; Sigurdsson H
ERBB2 amplification in breast cancer with a high rate of proliferation.
Oncogene 1991;6(1):137-43.
1991: Olsson H; Borg A; Fernö M; Möller T R; Ranstam J
Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.
Cancer detection and prevention 1991;15(4):265-71.
1991: Olsson H; Ingvar C
Left handedness is uncommon in breast cancer patients.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1694-5.
1990: Monti M; Brandt L; Ikomi-Kumm J; Olsson H
Heat production rate in blood lymphocytes as a prognostic factor in non-Hodgkin's lymphoma.
European journal of haematology 1990;45(5):250-4.
1990: Sigurdsson H; Baldetorp B; Borg A; Dalberg M; Fernö M; Killander D; Olsson H; Ranstam J
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.
British journal of cancer 1990;62(5):786-90.
1990: Kristoffersson U; Heim S; Johnsson A; Mandahl N; Olsson H; Akerman M; Mitelman F
Deletion of 14q in non-Hodgkin's lymphoma.
European journal of haematology 1990;44(4):261-4.
1990: Sigurdsson H; Baldetorp B; Borg A; Dalberg M; Fernö M; Killander D; Olsson H
Indicators of prognosis in node-negative breast cancer.
The New England journal of medicine 1990;322(15):1045-53.
1990: Brandt L; Johnson A; Olsson H; Akerman M
Mitotic activity and survival in advanced non-Hodgkin's lymphoma of unfavourable histology.
European journal of cancer (Oxford, England : 1990) 1990;26(3):227-30.
1990: Olsson H; Alm P; Aspegren K; Gullberg B; Jönsson P E; Ranstam J
Increased plasma prolactin levels in a group of men with breast cancer--a preliminary study.
Anticancer research 1990;10(1):59-62.
1990: Fernö M; Borg A; Johansson U; Norgren A; Olsson H; Rydén S; Sellberg G
Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.
Acta oncologica (Stockholm, Sweden) 1990;29(2):129-35.
1990: Olsson H
Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?
Medical oncology and tumor pharmacotherapy 1990;7(1):61-4.
1989: Olsson H; Möller T R; Ranstam J
Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
Journal of the National Cancer Institute 1989;81(13):1000-4.
1989: Brandt L; Kristoffersson U; Olsson H; Mitelman F
Relation between occupational exposure to organic solvents and chromosome aberrations in non-Hodgkin's lymphoma.
European journal of haematology 1989;42(3):298-302.
1989: Olsson H
Reproductive events, occurring in adolescence at the time of development of reproductive organs and at the time of tumour initiation, have a bearing on growth characteristics and reproductive hormone regulation in normal and tumour tissue investigated decades later--a hypothesis.
Medical hypotheses 1989;28(2):93-7.
1989: Olsson H
Oral contraceptives and breast cancer. A review.
Acta oncologica (Stockholm, Sweden) 1989;28(6):849-63.
1988: Kristoffersson U; Heim S; Mandahl N; Olsson H; Akerman M; Mitelman F
Trisomy 5 and t(5;14)(q11;q32) as the sole abnormalities in two different clones from a centroblastic non-Hodgkin's lymphoma.
Cancer genetics and cytogenetics 1988;36(2):173-6.
1988: Olsson H; Ranstam J
Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer.
Journal of the National Cancer Institute 1988;80(9):679-83.
1988: Olsson H; Möller T R; Ranstam J; Borg A; Fernö M
Early oral contraceptive use as a prognostic factor in breast cancer.
Anticancer research 1988;8(1):29-32.
1987: Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Anticancer research 1987;7(4B):853-6.
1987: Brandt L; Olsson H
Survival following combination chemotherapy in advanced high grade non-Hodgkin's lymphomas: relation to proliferative activity of the lymphoma cells.
European journal of haematology 1987;38(5):437-41.
1987: Olsson H; Ranstam J; Landin Olsson M
The number of menstrual cycles prior to the first full term pregnancy an important risk factor of breast cancer?
Acta oncologica (Stockholm, Sweden) 1987;26(5):387-9.
1986: Olsson H; Borg A; Ewers S B; Fernö M; Möller T; Ranstam J
A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Medical oncology and tumor pharmacotherapy 1986;3(2):77-81.

Sign-in to see more